A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy.

about

A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy.

Item

http://www.wikidata.org/entity/Q55377659

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

A Patient with Beta-Propeller ...... t with Iron Chelation Therapy.

@en

A Patient with Beta-Propeller ...... t with Iron Chelation Therapy.

@nl

type

Item

label

A Patient with Beta-Propeller ...... t with Iron Chelation Therapy.

@en

A Patient with Beta-Propeller ...... t with Iron Chelation Therapy.

@nl

prefLabel

A Patient with Beta-Propeller ...... t with Iron Chelation Therapy.

@en

A Patient with Beta-Propeller ...... t with Iron Chelation Therapy.

@nl

P1476

A Patient with Beta-Propeller ...... nt with Iron Chelation Therapy

@en

P2093

Ai Huey Tan

http://www.w3.org/2001/XMLSchema#string

Azlina Ahmad-Annuar

http://www.w3.org/2001/XMLSchema#string

Jia Lun Lim

http://www.w3.org/2001/XMLSchema#string

Mohamad Imran Idris

http://www.w3.org/2001/XMLSchema#string

Norlisah Ramli

http://www.w3.org/2001/XMLSchema#string

Ping Chong Bee

http://www.w3.org/2001/XMLSchema#string

Susanne A Schneider

http://www.w3.org/2001/XMLSchema#string

P2860

Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA.

Neuropathology of Beta-propeller protein associated neurodegeneration (BPAN): a new tauopathy

Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.

High frequency of beta-propeller protein-associated neurodegeneration (BPAN) among patients with intellectual disability and young-onset parkinsonism.

Patient Affected by Beta-Propeller Protein-Associated Neurodegeneration: A Therapeutic Attempt with Iron Chelation Therapy.

Treatable inherited rare movement disorders.

Selective iron chelation in Friedreich ataxia: biologic and clinical implications.

Beta Propellar Protein-Associated Neurodegeneration: A Rare Cause of Infantile Autistic Regression and Intracranial Calcification.

P304

89-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.14802/JMD.17082

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shen-Yang Lim

P577

2018-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29860786

http://www.w3.org/2001/XMLSchema#string

P921

chelation therapy

beta-propeller protein-associated neurodegeneration

P932

5990906

http://www.w3.org/2001/XMLSchema#string